Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Weiner JH – Families are not receiving accurate information regarding the expected potential benefits and limitations of immunoprophylaxis with palivizumab. This is a very expensive drug with unclear cost–effectiveness. If changes are to be made to current recommendations as to use of palivizumab, families must receive informed consent that accurately reflects the literature.


Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09

Today in Immuno/Infectious Dz...keeping you current

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/21/09

Influenza Management Guide 2009-2010
American Family Physician, 11/18/09

Bed bugs - What the GP needs to know
Australian Family Physician, 11/09/09

Today in Pulmonology...keeping you current

Anti-inflammatory drug therapy in asthma
Paediatric Respiratory Reviews, 11/02/09

A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency Department
Archives of Pediatrics and Adolescent Medicine, 11/23/09

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address